Summary
TUBB4A-related leukodystrophy is a disease where the brain’s white matter does not develop normally. White matter is also called myelin, which is a fatty substance that insulates nerves in the brain, like the plastic insulation around the cords for electrical wires for your appliances. Symptoms can show up at birth or later in childhood, often impacting movement, speech, and learning abilities.
Description
This disorder arises due to genetic changes in the TUBB4A gene, which normally helps makes special structures in your cells, called microtubules. Microtubules are essential for healthy brain function, and act like the roads in your cells, to get important parts of cells to the right place. Without those roads, the white matter of the brain cannot develop.
Patients with TUBB4A-related leukodystrophy can be affected differently. There are multiple subtypes, all tied to the same genetic cause, but ranging from severe early onset to milder forms in older children.
Some children present early in life, before their first birthday, and have severe trouble sitting, walking, and talking. Other children can present as toddlers when they lose abilities after initially developing them (developmental regression). Some children have a specific picture on their MRIs, which is sometimes called H-ABC, hypomyelination with atrophy of the basal ganglia and cerebellum). Rarely, children show milder issues, like muscle stiffness or mild learning difficulties.
Signs and Symptoms
Children may show:
- Delayed milestones, like late walking or talking
- Loss of previously learned skills (regression)
- Abnormal movements, such as involuntary muscle contractions or stiffness (dystonia, rigidity, choreoathetosis)
- Trouble with speech (dysarthria) and swallowing (dysphagia)
- Weak voice (dysphonia)
- Seizures (in some cases)
- Mild to severe learning difficulties
Causes
TUBB4A-related leukodystrophy is caused by variations in the TUBB4A gene. The gene change disrupts the formation of microtubules—structures in nerve cells that support proper development and transport inside the brain. Most cases are the result of a new (de novo) mutation and not inherited from a parent. Rarely, it may be inherited from a parent who does not show symptoms (mosaicism). Even more rarely, mildly affected children may inherit the variant from a mildly affected parent.
Laboratory Investigations
Key tests may include:
- MRI scans to identify loss of myelin and brain regions affected (especially basal ganglia and cerebellum)
- Genetic testing to confirm changes in the TUBB4A gene
- Clinical observation of movement, speech, and developmental milestones
Treatment and Therapies
There is no cure for TUBB4A-related leukodystrophy at this time. Treatments are focused on symptom management and support:
- Physical, occupational, and speech therapy to help maintain skills and function
- Medications may be tried for movement problems
- Seizure medications should be used when needed
- Nutritional and swallowing support
Families should be seen in a specialized clinic to create care plans tailored to each child's needs.
Outlook
The future for children with TUBB4A-related leukodystrophy depends on disease severity. Many children need help with daily activities and may never walk or speak independently. Mild cases might retain some abilities and independence. Ongoing therapies, educational support, and assistive devices often help children participate in daily life as much as possible.
Resources
The links and resources included in this section are solicited directly from the community by the Child Neurology Foundation through a formal submission process. CNF reserves the right to remove entities at any time if information is deemed inappropriate or inconsistent with the mission, vision, and values of CNF. The authors listed on this page have not endorsed the resources or links provided in this section.
The Foundation to Fight H-ABC/TUBB4A
To raise awareness, support families affected by H-ABC/ TUBB4A-related leukodystrophy, and drive research toward effective treatments—and ultimately, a cure—for Hypomyelination with Atrophy of the Basal Ganglia and Cerebellum (H-ABC) and TUBB4A-related leukodystrophy.
United Leukodystrophy Foundation
OUR MISSION is to provide support to the leukodystrophy community and enable platforms to accelerate improving patient quality of life and finding cures.
OUR VISION is to meet the needs of patients and families, whether newly diagnosed or living with a leukodystrophy. Through unified collaboration with advocacy groups, medical and research professionals, and pharma/biotech companies, we provide support, networking, and education to help navigate the journey of the disease.
Research
ClinicalTrials.gov for TUBB4A-Related Leukodystrophy (birth to 17 years)
These are clinical trials that are recruiting or will be recruiting. Updates are made daily, so you are encouraged to check back frequently.
ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. This is a resource provided by the U.S. National Library of Medicine (NLM), which is an institute within the National Institutes of Health (NIH). Listing a study does not mean it has been evaluated by the U.S. Federal Government. Please read the NLM disclaimer for details.
Before participating in a study, you are encouraged to talk to your health care provider and learn about the risks and potential benefits.
For more information about participation in clinical trials, check out our education hub on the topic here.
The information in the CNF Child Neurology Disorder Directory is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. Content provided is for informational purposes only. CNF is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options.
References
- MedlinePlus Genetics. TUBB4A-related leukodystrophy [Internet]. Bethesda (MD): National Library of Medicine (US); 2015 [cited 2025 Sep 15]. Available from: https://medlineplus.gov/genetics/
- United Leukodystrophy Foundation. TUBB4A-Related Leukodystrophy Study [Internet]. Sycamore (IL): United Leukodystrophy Foundation; 2025 [cited 2025 Sep 15]. Available from: https://ulf.org/
- NCBI GeneReviews. TUBB4A-Related Leukodystrophy [Internet]. Seattle (WA): University of Washington, Seattle; 2016 [cited 2025 Sep 15]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK
- ScienceDirect. The natural history of variable subtypes [Internet]. Amsterdam (NL): Elsevier; 2025 [cited 2025 Sep 15]. Available from: https://www.sciencedirect.com/
- MalaCards. TUBB4A-Related Leukodystrophy [Internet]. Rehovot (IL): LifeMap Sciences; 2025 [cited 2025 Sep 15]. Available from: https://www.malacards.org/
- Alex TLC. TUBB4A-associated leukodystrophy: Disease and search for treatment [Internet]. London (UK): Alex The Leukodystrophy Charity; 2025 [cited 2025 Sep 15]. Available from: https://www.alextlc.org/
- PubMed Central (PMC). TUBB4A-related hypomyelinating leukodystrophy [Internet]. Bethesda (MD): National Institutes of Health; 2016 [cited 2025 Sep 15]. Available from: https://pmc.ncbi.nlm.nih.gov/
- Perplexity AI, Inc. Perplexity [Internet]. San Francisco (CA): Perplexity AI, Inc.; 2025 [cited 2025 Oct 24]. Available from: https://www.perplexity.ai
This overview is for general information and is not a substitute for advice from your child's care team.
← Back to the Disorder Directory